These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22585705)

  • 1. Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma.
    Khan S; Chen CL; Brady MS; Parameswaran R; Moore R; Hassoun H; Carvajal RD
    J Clin Oncol; 2012 Jun; 30(18):e163-4. PubMed ID: 22585705
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthermic isolated regional perfusion of the limb with carboplatin.
    Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ
    Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
    Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
    Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
    Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
    J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy of carboplatin and paclitaxel for metastatic melanoma.
    Sato Y; Uhara H; Ashida A; Okuyama R
    J Dermatol; 2013 Dec; 40(12):1050-1. PubMed ID: 24330169
    [No Abstract]   [Full Text] [Related]  

  • 6. Enterocolitis in a patient being treated with ipilimumab for metastatic melanoma.
    Koch C; Paetzold S; Trojan J
    Gastroenterology; 2012 Aug; 143(2):298, 504, 505. PubMed ID: 22709738
    [No Abstract]   [Full Text] [Related]  

  • 7. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
    Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M
    Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2-associated bullous drug dermatosis.
    Hofmann M; Audring H; Sterry W; Trefzer U
    Dermatology; 2005; 210(1):74-5. PubMed ID: 15604553
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of metastatic malignant melanoma of the lower limb treated with hyperthermic isolated limb perfusion and concomitant infusion of either carboplatin or beta-interferon.
    Nakayama J; Takeuchi M; Mayumi H; Nagae S; Matsuda K; Yasui H; Takahashi S; Hori Y
    J Dermatol; 1996 Jan; 23(1):6-15. PubMed ID: 8720252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
    Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
    Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular swelling as the presenting sign of cutaneous malignant melanoma.
    Hida T; Saga K; Ogino J; Kagaya M; Kamada A; Kaneko R; Jimbow K; Inoue R; Takahashi A
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):351-3. PubMed ID: 16503910
    [No Abstract]   [Full Text] [Related]  

  • 14. The systemic treatment of advanced cutaneous melanoma.
    Logan TF
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose platinum combination therapy in pretreated patients with disseminated melanoma.
    Hofmann MA; Gabriel V; Milling A; Kiecker F; Sterry W; Trefzer U
    Chemotherapy; 2007; 53(6):422-8. PubMed ID: 17952002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
    Hemrajani RH; Kim KB; Amos WR; Mann DE
    Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

  • 18. Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma.
    Mechl Z; Krejcí P
    Neoplasma; 1983; 30(3):371-7. PubMed ID: 6683360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.